Section 440IAC10-4-25. Patient compliance with program rules  


Latest version.
  •    (a) To remain enrolled in the program, a patient shall do the following:

    (1) Comply with program rules and expectations.

    (2) Demonstrate progress toward identified goals.

      (b) A violation of program rules by a patient may result in either of the following:

    (1) A medically supervised reduction of opioid treatment medication.

    (2) The patient's termination from the program.

    However, a patient's continued use of an illicit drug or drugs or a patient's nonpayment of fees is not a sufficient justification for termination or discharge of the patient from the OTP, unless the patient refuses to cooperate with the patient's treatment plan.

      (c) Violations of OTP rules for which a patient may be subject to discharge from the OTP include, but are not limited to, the following:

    (1) Threats of violence or actual violence toward staff or another patient.

    (2) Other disruptive behavior.

    (3) Community incidents, including, but not limited to, any of the following:

    (A) Loitering near the OTP.

    (B) The diversion of opioid treatment medication.

    (C) The sale or purchase of illicit drugs.

    (4) Continued unexcused absences from counseling and other OTP services.

    (5) An involvement in criminal activities.

    (6) Any other OTP rule violation.

      (d) At the discretion of the medical director, a patient may be moved to a level of treatment necessary to reestablish stability if the patient does any of the following:

    (1) Relapses to the illicit use of controlled substances.

    (2) Abuses alcohol.

    (3) Ceases to progress in treatment.

      (e) The OTP shall have written policies and procedures that address the consequences of a patient testing positive for the following:

    (1) A drug for which the patient does not have a prescription.

    (2) A drug which is not part of the patient's treatment plan.

      (f) The OTP shall provide its written policies and procedures to a patient within seven (7) days of admission. (Division of Mental Health and Addiction; 440 IAC 10-4-25; filed Dec 30, 2009, 2:00 p.m.: 20100127-IR-440080412FRA; readopted filed May 10, 2016, 11:24 a.m.: 20160608-IR-440160134RFA)